RO 7268489
Alternative Names: RO-7268489Latest Information Update: 17 May 2024
At a glance
- Originator Roche
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 14 May 2024 Roche plans a phase I pharmacokinetics trial (In volunteers) in Netherlands (PO, capsule) in June 2024 (EudraCT20245106068500) (ISRCTN14119236)
- 10 May 2023 Phase-I clinical trials in Unspecified (In volunteers) in USA (PO) (ISRCTN36003543)
- 21 Feb 2023 Phase-I clinical trials in Unspecified (In volunteers) in Netherlands (PO) (ISRCTN74851494)